期刊文献+

N—myc蛋白表达对神经母细胞瘤SK-N-BE(2)细胞增殖迁移的影响 被引量:1

Decreased expression of N-myc protein inhibits cell proliferation and migration of neuroblastoma cell line SK-N-BE(2)
原文传递
导出
摘要 【摘要】目的MYCN基因高扩增是神经母细胞瘤(neuroblastoma,NB)预后的重要指标,其表达蛋白N-myc在NB发生发展中的意义尚存在争议。我们以MYCN基因高扩增NB细胞株SK—N-BE(2)为研究对象,探讨N-mye表达对细胞增殖、迁移的影响及可能机制。方法设计构建MYCNsiRNA;转染NB细胞株SK—N—BE(2),采用RT-PCR法和Western-blot法检测表达抑制情况;抑制N-myc表达后,用BrdU(colorimetricbromodeoxyuridine)试剂盒检测细胞增殖能力变化,Tr—answell(Costar)系统检测细胞迁移能力变化;Western-blot法检验RACKl、Src、Akt、ERKl/2及P38表达和磷酸化改变。结果对照组mRNA表达值(设为1),RT-PCR检测显示转染siRNA的SK-N-BE(2)细胞中N—mycmRNA表达(().34±0.06)与对照组比较,差异有统计学意义(P〈().05)。Western-blot检测结果显示,转染siRNA的SK—N-BE(2)细胞中N—myc蛋白表达(0.61±0.15)与对照组(1.97±0.26)比较显著降低,差异有统计学意义(P%0.05)。设定对照组迁移、增殖能力为1,N—mye表达降低后SK—N—BE(2)细胞的迁移能力(0.85±0.06)和增殖能力(O.68±0.05)均显著下降,差异有统计学意义(P〈0.05)。伴随细胞的增殖和迁移能力下降,出现RACKl(对照组1.46±0.18VSN—mycRNAi组1.13±0.10)和磷酸化Src(Tye416)(对照组1.34±0.11VSN—mycRNAi组0.72±0.23)表达降低,磷酸化Akt表达增加(对照组0.55±0.12VSN—mycRNAi组0.84±0.15),差异有统计学意义(P%0.05)。磷酸化Src(Tye527),磷酸化ERKl/2、磷酸化p38的表达无显著变化,差异无统计学意义(P〉0.05)。结论在MYCN高扩增、高表达NB细胞株SK-N—BE(2)中N-myc表达下降可抑制肿瘤细胞增殖和迁移,其机制可能同RACKl、Src,Akt的表达或活化有关。 [Abstract] Objective To investigate the roles of Nmyc in migration and proliferation of neuro blastoma (NB). Methods The N-myc siRNA was transfected to NB cell line SK-N-BE(2). The effi- ciency of gene silence was confirmed by real time RT-PCR and western-blot. After N-myc silencing, cell migration and proliferation were detected by transwell system and eolorimetric BrdU assay. The expressions of RACK1, N-myc, phospho-Src ( Tyr416), phospho-Src ( Tyr527 ), phospho-Akt, phospho- ERK1/2 and phospho p38 were analyzed by western blotting. Results When the expression of N-Myc protein was significantly reduced (0. 61 ± 0. 15 vs 1.97-± 0. 26,_P〈0. 05),the migration (0. 85 ± 0. 06) and proliferation (0.68 ± 0.05) of SK-N-BE(2) were significantly decreased (P〈0.05). The expres- sions of RACK1 (Control group l. 46 ± 0. 18 vs RNAi group 1.13 ± 0. 10) and phospho-Src(Tye416) (Control group 1.34 ± 0. ll vs RNAi group 0. 72 ±0. 23) were also significantly decreased (P〈 0.05) ,while the expression of phospho-Akt (Control group 0. 551 9 ± 0. 121 9 vs RNAi group 0. 8360 ± 0. 153 5)was significantly increased (P〈0. 05). The expressions of phospho-Src(Tye527), phospho- ERK1/2 and phospho-p38 were not changed significantly by N-Myc gene silencing in SK-N-BE(2) (P〈0. 05). Conclusions These results suggest that the high expression of N-myc in SK-N-BE(2) is crucial for cell migration and proliferation. The expressions of RACK1, phosphorylation of Src (Tye416) and Akt might be involved in the N-myc-induced migration and proliferation of NB.
出处 《中华小儿外科杂志》 CSCD 北大核心 2013年第6期450-453,共4页 Chinese Journal of Pediatric Surgery
基金 国家自然科学基金青年科学基金项目(编号:30801200)
关键词 原癌基因蛋白质C-MYC 神经母细胞瘤 细胞增殖 细胞凋亡 Proto-oncogene proteins c-myc ~ Neuroblastoma Cell proliferation Apoptosis
  • 相关文献

参考文献17

  • 1Park JR,Eggert A,Caron H. Neuroblastoma:biology, progno-sis, and treatment. Hematol Oncol Clin North Am, 2010, 24:65-86.
  • 2Maris JM. Recent advances in neuroblastoma. N Eng J Med,2010,362(23):2202-2211.
  • 3Cohn SL,Tweddle DA. MYCN amplification remains prognos-tically strong 20 years after its “clinical debut”. Eur J Cancer,2004,40(18):2639-2642.
  • 4Tang XX,Zhao H,Kung B, et al. The MYCN enigma:signifi-cance of MYCN expression in neuroblastoma. Cancer Res,2006.66(5):2826-2833.
  • 5Kang JH,Rychahou PG,Ishola TA,et al. MYCN silencing in-duces differentiation and apoptosis in human neuroblastomacells. Biochem Biophys Res Commun,2006,351(1); 192-197.
  • 6吕凡,张弛,严文波,潘伟华,周莹,施诚仁.短链RNA抑制神经母细胞瘤MYCN基因表达诱发肿瘤细胞凋亡的研究[J].中华小儿外科杂志,2009,30(3):155-158. 被引量:3
  • 7Zaizen Y,Taniguchi S, Suita S. The role of cellular motility inthe invasion of human neuroblastoma cells with or without N-myc amplification and expression. J Pediatr Surg, 1998,33(12):1765-1770.
  • 8Kumar S,Weaver VM. Mechanics,malignancy,and metastasis:the force journey of a tumor cell. Cancer Metastasis Rev,2009,28(1-2):113-127.
  • 9Adams DR, Ron D,Kiely PA. RACKl, A multifaceted scaffol-ding protein:structure and function* Cell Commun Signal,2011,9:22.
  • 10Li J,Guo Y, Feng X, et al. Receptor for activated C kinase 1(RACKl):a regulator for migration and invasion in oral squa-mous cell carcinoma cells. J Cancer Res Clin Oncology,2012,138(4):563-571.

二级参考文献11

  • 1Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma. Lancet, 2007,369 : 2106-2120.
  • 2Schwab M. MYCN in neuronal tumors. Cancer Lett,2004,204: 179-187.
  • 3Tang XX, Zhao HQ, Kung B, et al. The MYCN enigma: Significance of MYCN expression in neuroblastoma. Cancer Res, 2006,66: 2826-2833.
  • 4Wagner LM, Burger RA, Guichard SM, et al. Pilot study to evaluate MYCN expression as a neuroblastoma cell marker to detect minimal residual disease by RT PCR. J Pediatr Hematol Oncol, 2006,28 : 635-641.
  • 5Bagatell R, Rumcheva P, London WB, et al. Outcomes of children with intermediate-risk neuroblastoma after reatment stratified by MYCN status and tumor cell ploidy. J Clin Oncol,2005, 23:8819-8827.
  • 6Anderson J, Gibson S, Williamson D, et al. Rapid and accurate determination of MYCN copy number and lp deletion in neuroblastoma by quantitative PCR. Pediatr Blood Cancer, 2006,46: 820- 824.
  • 7Moreau LA,McGrady P, London WB, et al. Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group Study. Clin Cancer Res, 2006, 12: 5693- 5697
  • 8Fjose A, Drivenes O. RNAi and microRNAs: from animal models to disease therapy. Birth Defects Res C Embryo Today, 2006,78 : 150-171.
  • 9Bertrand JR, Pottier M, Vekris A, el al. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun,2002,296:1000-1004.
  • 10Morris KV, Chan SW, Jacobsen SE, et al. Small interfering RNA-induced transcriptional gene silencing in human cells. Science, 2004,305:1289-1292.

共引文献2

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部